May 17, 2024 | 12:41 GMT +7
May 17, 2024 | 12:41 GMT +7
Hotline: 0913.378.918
(VAN) Bayer's CEO said on Friday that the healthcare and crop chemicals group continues to firmly back its glyphosate weedkiller even after a recent courtroom loss in U.S. litigation over an alleged carcinogenic effect.
(VAN) The European Commission’s decision to reauthorize the herbicide for 10 years is being challenged in three separate legal actions.
(VAN) It has been a quarter century since corn and soybeans were engineered to withstand the withering mists of the herbicide glyphosate.
(VAN) Could the controversial herbicide be prohibited across the European Union member states?
(VAN) Weak demand for glyphosate-based weed killers led Bayer (BAYGn.DE) to cut its full-year earnings outlook for the second time and announce a 2.5 billion euro ($2.8 billion) write-down on glyphosate-related assets.